Predicting non-compliance to pancreatic enzyme supplementation therapy in chronic pancreatitis: A machine learning-based approach
摘要
Chronic pancreatitis results in pancreatic exocrine insufficiency (PEI), which is treated with pancreatic enzyme replacement therapy (PERT). Despite the clinical benefits, non-compliance to PERT is a frequent problem. Our study aimed at (a) identifying predictors of non-compliance to PERT using machine learning (ML) algorithms and (b) analyzing patient-reported reasons for non-compliance to PERT.
MethodsA prospective observational study was conducted at a high-volume tertiary care center on two independent cohorts of chronic pancreatitis patients on PERT. In Cohort 1 (1057 patients screened), we used ML algorithms to identify predictors of non-compliance to PERT. The best ML model based on performance metrics was chosen for Shapley Additive explanations (SHAP) analysis. In Cohort 2 (465 patients screened), we conducted detailed interviews to understand patient-reported reasons for non-compliance.
ResultsIn Cohort 1 (751 patients analyzed; median age, 37.5 years; males, 73.1%; idiopathic, 61.9%), 166 (22.1%) patients were non-compliant to PERT. Extreme gradient boosting (XGBoost) exhibited the highest accuracy (area under the curve, AUC = 0.91). The strongest predictors of non-compliance based on SHAP were disease duration, age, fat-restricted diet, rural residence and educational status. A non-compliance (NC) score was developed based on SHAP. In Cohort 2 (129 patients analyzed; mean age, 36 years; males, 72.1%; idiopathic, 52.3%), high treatment costs (34.1%), negligence (19.4%) and adverse effects (10.9%) were the most reported reasons for non-compliance.
ConclusionsThis study identifies predictors of non-compliance to PERT (disease duration, age, fat-restricted diet, rural habitat, undergraduate education status) in patients with chronic pancreatitis using machine-learning algorithms. The NC score can be a useful tool to identify patients at risk for non-compliance, who can be subjected to targeted counselling. The NC score needs to be validated in large, independent, multi-centre cohorts of patients.
Graphical Abstract